Jon H Condra

Title: Jon H Condra: Innovator in PCSK9 Antagonists

Introduction

Jon H Condra is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of PCSK9 antagonists. With a total of seven patents to his name, Condra's work has the potential to impact the treatment of various health conditions.

Latest Patents

Among his latest patents are the 1B20 PCSK9 antagonists and AX132 PCSK9 antagonists. These inventions focus on antagonists of human proprotein convertase subtilisin-kexin type 9 (PCSK9). The disclosed antagonists are effective in inhibiting PCSK9 function, making them valuable for treating conditions associated with PCSK9 activity. Additionally, the patents include nucleic acids encoding these antagonists, vectors, host cells, and compositions that comprise the antagonists. Methods for creating PCSK9-specific antagonists and their applications for inhibiting or antagonizing PCSK9 function are also detailed in these patents.

Career Highlights

Jon H Condra has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck Sharpe & Dohme Corp. His experience in these organizations has contributed to his expertise in the development of innovative treatments.

Collaborations

Throughout his career, Condra has collaborated with talented individuals such as Rose M Cubbon and Shilpa Pandit. These collaborations have likely enriched his research and development efforts.

Conclusion

Jon H Condra is a distinguished inventor whose work on PCSK9 antagonists holds promise for advancing medical treatments. His contributions to the field are noteworthy and reflect his commitment to innovation in biochemistry.